Clinical News and Research

RSS

Future of AI in Life Science Research

In partnership with the SLAS 2022 exhibition and conference, we speak to Brian O’Sullivan about artificial intelligence and its future within the life sciences sector.

From Society for Laboratory Automation and Screening (SLAS) 1 Mar 2022

MIP Diagnostics secures £7.3M investment following achievement of critical milestones

Mercia Asset Management, Calculus Capital, Downing Ventures and BGF scale joint investment in latest fundraise.

From MIP Discovery 1 Mar 2022

Novel molecular pathway shared by ALS and frontotemporal dementia identified

Scientists from two independent research teams have discovered how the mislocalization of a protein, known as TDP-43, alters the genetic instructions for UNC13A, providing a possible therapeutic target that could also have implications in treating amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and other forms of dementia.

1 Mar 2022

Microbes hindering cancer therapy seem to play a bigger role than helpful ones

Melanoma patients receiving therapy that helps their immune system kill cancer cells respond to treatment differently depending on the types of microbes in their gut, and new research suggests the microorganisms hindering therapy have more influence than the beneficial ones.

1 Mar 2022

Looking at protein activity gives a complete picture of leukemia's weaknesses

Blocking a protein chain reaction makes childhood leukemia cells more sensitive to an existing targeted treatment, a new study shows.

28 Feb 2022

New computational tool simulates evolution

The building blocks of life-saving therapeutics could be developed in days instead of years thanks to new software that simulates evolution.

25 Feb 2022

Scientists elucidate mechanism that causes treatment resistance in aggressive pancreatic cancer

Drug resistance is a major obstacle in the treatment of cancers. In an aggressive type of pancreatic cancer, for instance, drug resistance is associated with the suppression of programmed cell death, which results in the uncontrolled growth of cancer cells.

25 Feb 2022

Study identifies a new cancer cell state related to poor treatment response in ovarian cancer patients

The prognosis for ovarian cancer patients is grim: less than half of high-grade serous ovarian cancer (HGSC) patients survive past five years from diagnosis. Initially, the tumors typically respond well to chemotherapy but become resistant after repeated treatments, enabling the cancer to regrow.

24 Feb 2022

New technique uses microscopic magnetic particles to remotely activate brain cells

Scientists at UCL have developed a new technique that uses microscopic magnetic particles to remotely activate brain cells; researchers say the discovery in rats could potentially lead to the development of a new class of non-invasive therapies for neurological disorders.

From University College London 24 Feb 2022

Study decodes the heterogeneity of tumor-infiltrating immune cell composition in diffuse large B-cell lymphoma

In Finland, about 700 people are identified with diffuse large B-cell lymphoma (DLBCL) every year.

24 Feb 2022

Using sound waves to turn stem cells into bone cells

Researchers have used sound waves to turn stem cells into bone cells, in a tissue engineering advance that could one day help patients regrow bone lost to cancer or degenerative disease.

23 Feb 2022

TGen collaborates with Deepcell to employ AI for analyzing single cell morphology

The Translational Genomics Research Institute, an affiliate of City of Hope, is partnering with a Silicon Valley firm to become one of the first research institutes in the world to employ a new Artificial Intelligence-powered imaging and sorting technology to classify and isolate individual diseased cells.

23 Feb 2022

Newly developed radio-labeled molecule may be able to pinpoint areas of inflammation

Researchers at The University of Texas MD Anderson Cancer Center have developed a new radio-labeled molecule capable of selectively reacting with certain high-energy radicals that are characteristic of innate immune activity, which may allow a non-invasive approach to monitor inflammation in real time by positron emission tomography (PET) imaging.

22 Feb 2022

Researchers employ genetic testing to determine the risk of developing cardiovascular disease

Dignity Health in Arizona is introducing the first research study in North America that will use genetic testing to pinpoint men and women who are at risk of developing a cardiovascular disease based on the composition of their DNA.

22 Feb 2022

Researchers study the impact of broad-spectrum antibiotics on the infants’ microbiome

A recent study proves that antibiotic use in the first week of birth is associated with a reduction in the number of healthy bacteria required to digest milk.

22 Feb 2022

Experts identify critical genes that cause coronary heart disease and trigger heart attacks

Recent research identified the major genes involved in coronary heart disease and cardiac arrest.

21 Feb 2022

Lifelong exercise may help counteract the deterioration of fat tissue function with age

Fat tissue plays an important role in human health. However, our fat tissue loses function as we age, which can lead to type 2 diabetes, obesity, cancer and other ailments.

18 Feb 2022

Experts trigger apoptosis in leukemia cells by disrupting their energy maintenance mechanism

A group of researchers from UNIGE in Switzerland and Inserm in France has discovered a previously unknown process that could lead to the creation of novel medicines.

18 Feb 2022

Researchers engineer strains of nitrogen-fixing soil bacterium to produce ammonia

Researchers from Washington State University have engineered strains of the ubiquitous, nitrogen-fixing soil bacterium Azotobacter vinelandii to produce ammonia and excrete it at high concentrations, transferring it into crop plants in lieu of conventional chemical fertilizers.

18 Feb 2022

CNIO researchers design new platform to test drugs for possible use in brain metastases

It is estimated that about a quarter of cancer patients are at risk of brain metastases, a rate that is increasing especially among those who suffer relapses after having undergone different cancer treatments.

18 Feb 2022

Clinical News and Research

Future of AI in Life Science Research

MIP Diagnostics secures £7.3M investment following achievement of critical milestones

Novel molecular pathway shared by ALS and frontotemporal dementia identified

Microbes hindering cancer therapy seem to play a bigger role than helpful ones

Looking at protein activity gives a complete picture of leukemia's weaknesses

New computational tool simulates evolution

Scientists elucidate mechanism that causes treatment resistance in aggressive pancreatic cancer

Study identifies a new cancer cell state related to poor treatment response in ovarian cancer patients

New technique uses microscopic magnetic particles to remotely activate brain cells

Study decodes the heterogeneity of tumor-infiltrating immune cell composition in diffuse large B-cell lymphoma

Using sound waves to turn stem cells into bone cells

TGen collaborates with Deepcell to employ AI for analyzing single cell morphology

Newly developed radio-labeled molecule may be able to pinpoint areas of inflammation

Researchers employ genetic testing to determine the risk of developing cardiovascular disease

Researchers study the impact of broad-spectrum antibiotics on the infants’ microbiome

Experts identify critical genes that cause coronary heart disease and trigger heart attacks

Lifelong exercise may help counteract the deterioration of fat tissue function with age

Experts trigger apoptosis in leukemia cells by disrupting their energy maintenance mechanism

Researchers engineer strains of nitrogen-fixing soil bacterium to produce ammonia

CNIO researchers design new platform to test drugs for possible use in brain metastases

Driving Support for Pharmaceutical Testing Through Continuous Innovation

From Memory to Metaplasticity: Unraveling the Brain's Secrets

Revolutionizing Mass Spectrometry: A Deep Dive into Plasmion’s SICRIT® Technology

Latest in Genomics